Both in Pharmaceuticals
Xenon Pharmaceuticals vs Organon &
Over the past year XENE returned −4.6% and OGN returned +32.8%; their daily moves had a correlation of 0.00.
XENE −4.6% OGN +32.8%Growth of $1, one year, split-adjusted
| Metric | XENE | OGN |
|---|---|---|
| Price | $37.25 | $13.74 |
| Market cap | $3.61B | $3.61B |
| Today | +1.44% | +0.07% |
| 1 month | −37.9% | −0.1% |
| 6 months | −32.9% | +141.1% |
| Year to date | −16.9% | +91.6% |
| 1 year | −1.9% | +34.6% |
| Revenue growth (YoY) | — | −2.3% |
| Gross margin | — | 54.4% |
| Net margin | — | 6.9% |
| P/E (TTM) | — | 17.3× |
| Price / sales | — | 0.6× |
| Net cash | $930.7M | -$7.42B |
| Dividend yield | — | 0.58% |
| Volatility (60d) | 84.0% | 2.8% |
| Short % of float | 7.1% | 6.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).